Goldman Sachs Group Inc Codexis, Inc. Transaction History

Goldman Sachs Group Inc

$706 Billion
Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in Codexis, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 448,770 shares of CDXS stock, worth $915,490. This represents 0.0% of its overall portfolio holdings.

Number of Shares

448,770

Previous 309,086 45.19%

Holding current value

$915,490

Previous $831,000 31.65%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.97 - $2.64 $275,177 - $368,765	139,684 Added 45.19%	448,770 $1.09 Million
Q1 2025 May 09, 2025	SELL	$2.53 - $5.43 $552,898 - $1.19 Million	-218,537 Reduced 41.42%	309,086 $831,000
Q4 2024 Feb 11, 2025	SELL	$2.91 - $5.81 $80,071 - $159,867	-27,516 Reduced 4.96%	527,623 $2.52 Million
Q3 2024 Nov 14, 2024	BUY	$2.62 - $3.71 $198,776 - $281,473	75,869 Added 15.83%	555,139 $1.71 Million
Q2 2024 Aug 13, 2024	BUY	$2.65 - $3.92 $723,317 - $1.07 Million	272,950 Added 132.29%	479,270 $1.49 Million
Q1 2024 May 15, 2024	SELL	$2.59 - $4.65 $125,949 - $226,124	-48,629 Reduced 19.07%	206,320 $720,000
Q4 2023 Feb 13, 2024	SELL	$1.54 - $3.37 $203,236 - $444,745	-131,972 Reduced 34.11%	254,949 $777,000
Q3 2023 May 14, 2024	BUY	$1.5 - $3.75 $197,958 - $494,895	131,972 Added 51.76%	386,921 $731,000
Q3 2023 Nov 14, 2023	BUY	$1.5 - $3.75 $125,535 - $313,837	83,690 Added 27.6%	386,921 $731,000
Q2 2023 May 14, 2024	BUY	$2.21 - $4.43 $23,894 - $47,897	10,812 Added 3.7%	303,231 $849,000
Q2 2023 Aug 14, 2023	BUY	$2.21 - $4.43 $23,894 - $47,897	10,812 Added 3.7%	303,231 $849,000
Q1 2023 May 14, 2024	SELL	$3.81 - $6.76 $4.28 Million - $7.6 Million	-1,123,652 Reduced 79.35%	292,419 $1.21 Million
Q1 2023 May 11, 2023	SELL	$3.81 - $6.76 $4.28 Million - $7.6 Million	-1,123,652 Reduced 79.35%	292,419 $1.21 Million
Q4 2022 May 14, 2024	BUY	$4.26 - $6.84 $540,772 - $868,283	126,942 Added 9.85%	1,416,071 $6.6 Million
Q4 2022 Feb 13, 2023	BUY	$4.26 - $6.84 $540,772 - $868,283	126,942 Added 9.85%	1,416,071 $6.6 Million
Q3 2022 May 14, 2024	SELL	$6.06 - $12.86 $2.41 Million - $5.11 Million	-397,385 Reduced 23.56%	1,289,129 $7.81 Million
Q3 2022 Nov 10, 2022	SELL	$6.06 - $12.86 $2.41 Million - $5.11 Million	-397,385 Reduced 23.56%	1,289,129 $7.81 Million
Q2 2022 May 14, 2024	BUY	$8.35 - $21.89 $12 Million - $31.3 Million	1,431,565 Added 561.51%	1,686,514 $17.6 Million
Q2 2022 Aug 15, 2022	BUY	$8.35 - $21.89 $1.78 Million - $4.67 Million	213,421 Added 14.49%	1,686,514 $17.6 Million
Q1 2022 May 16, 2022	BUY	$16.97 - $31.93 $4.69 Million - $8.83 Million	276,664 Added 23.12%	1,473,093 $30.4 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $41.78 $1.21 Million - $1.98 Million	-47,433 Reduced 3.81%	1,196,429 $37.4 Million
Q3 2021 Nov 10, 2021	BUY	$19.65 - $27.99 $24.4 Million - $34.8 Million	1,243,862 New	1,243,862 $28.9 Million

Others Institutions Holding CDXS

# of Institutions

129

Shares Held

66.7M

Call Options Held

25.8K

Put Options Held

20K

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $134M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Codexis, Inc. Transaction History